2024-05-08 09:28:23
“The Times” newspaper reported, “Experts from Britain and the United States have developed a technology for a new vaccine capable of protecting against a group of coronaviruses that infect humans, even ones that have not yet been discovered.”
The newspaper explained, “Scientists from the Universities of Oxford, Cambridge, and the California Institute of Technology in California used a new approach called “proactive vaccinology” to build a vaccine before the disease-causing agent becomes a threat.”
The newspaper reported, “The vaccine was tested on mice, and it works by training the immune system to recognize parts of eight coronaviruses, including several that circulate in bats and could one day infect humans.”
According to the newspaper, the results of the experiment found that “the new vaccine gave a broad immune response, even in mice vaccinated against the strain responsible for the Covid-19 pandemic.”
Professor Mark Howarth, from the Department of Pharmacology at the University of Cambridge and lead author of the research, said: “We know enough about coronaviruses and the different immune responses to them that we can start to build protective vaccines against now unknown coronaviruses.”
“Our focus is on creating a vaccine that will protect us from the next coronavirus pandemic, and be ready before the pandemic starts,” said Rory Hills, a graduate researcher in the Department of Pharmacology at the University of Cambridge and first author of the research.
“We have created a vaccine that provides protection against a wide range of different coronaviruses, including ones we don’t know about yet,” Hills added.
Suggest a correction
2024-05-08 09:28:23